These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 10746809
1. Iron metabolism in rhEPO-treated hemodialysis patients. Schaefer RM, Bahner U. Clin Nephrol; 2000 Feb; 53(1 Suppl):S65-8. PubMed ID: 10746809 [Abstract] [Full Text] [Related]
4. Monitoring iron status in end-stage renal disease patients on hemodialysis. Rafi A, Karkar A, Abdelrahman M. Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895 [Abstract] [Full Text] [Related]
5. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients. Canavese C, Grill A, Decostanzi E, Maddalena E, Barbieri S, Martina G, Fop F, Buglione E, Grechi D, David O, Saitta M, Piccoli G. Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481 [Abstract] [Full Text] [Related]
7. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R. J Matern Fetal Med; 1999 Jan; 8(1):1-7. PubMed ID: 10052837 [Abstract] [Full Text] [Related]
8. Iron requirements in erythropoietin therapy. Eschbach JW. Best Pract Res Clin Haematol; 2005 Jun; 18(2):347-61. PubMed ID: 15737895 [Abstract] [Full Text] [Related]
9. Evaluating iron status in hemodialysis patients. Enders HM. Nephrol Nurs J; 2002 Aug; 29(4):366-70. PubMed ID: 12224370 [Abstract] [Full Text] [Related]
10. Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study. Krafft A, Perewusnyk G, Hänseler E, Quack K, Huch R, Breymann C. BJOG; 2005 Apr; 112(4):445-50. PubMed ID: 15777442 [Abstract] [Full Text] [Related]
13. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. Hackeng CM, Beerenhout CM, Hermans M, Van der Kuy PH, Van der Dussen H, Van Dieijen-Visser MP, Hamulyák K, Van der Sande FM, Leunissen KM, Kooman JP. J Nephrol; 2004 Apr; 17(1):107-11. PubMed ID: 15151266 [Abstract] [Full Text] [Related]
14. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Chen YC, Hung SC, Tarng DC. Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299 [Abstract] [Full Text] [Related]
17. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin. Arndt U, Kaltwasser JP, Gottschalk R, Hoelzer D, Möller B. Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327 [Abstract] [Full Text] [Related]
18. [Serum ferritin and iron therapy in patients treated with periodic hemodialysis]. Docci D, Cenciotti L, Turci F, Salvi G, Mosconi G, Baldrati L. Quad Sclavo Diagn; 1982 Dec; 18(4):454-62. PubMed ID: 7186648 [Abstract] [Full Text] [Related]
19. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. Schaefer RM, Schaefer L. J Perinat Med; 1995 Dec; 23(1-2):83-8. PubMed ID: 7658326 [Abstract] [Full Text] [Related]